{"transactions":[{"id":860790,"issuer":{"id":5011,"kind":"organization","name":"Annexon, Inc.","symbol":"ANNX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-03-04T21:30:46.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":5820,"price":5.43,"value":31602.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $5.36 to $5.57, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":123582,"source":{"system":"sec-edgar","filing":"0001734424-26-000003","document":"form4-03042026_040342.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528115/000173442426000003/form4-03042026_040342.xml","form_type":"4"}},{"id":887592,"issuer":{"id":5011,"kind":"organization","name":"Annexon, Inc.","symbol":"ANNX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-24T00:09:58.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from February 19, 2026 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":225000,"derivative":{"exercise_price":5.1,"expiration_date":"2036-02-19","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001734424-26-000002","document":"form4-02242026_120253.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1528115/000173442426000002/form4-02242026_120253.xml","form_type":"4"}},{"id":887591,"issuer":{"id":5011,"kind":"organization","name":"Annexon, Inc.","symbol":"ANNX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-02-24T00:09:58.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":56250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on February 19 of each year, with the first 1/3rd vesting on February 19, 2027, subject to Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":129402,"source":{"system":"sec-edgar","filing":"0001734424-26-000002","document":"form4-02242026_120253.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528115/000173442426000002/form4-02242026_120253.xml","form_type":"4"}},{"id":890286,"issuer":{"id":5011,"kind":"organization","name":"Annexon, Inc.","symbol":"ANNX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-02-20T21:30:24.000Z","date":"2026-02-18","kind":"sale","planned":false,"acquired":false,"shares":5290,"price":5.1,"value":26979.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $4.93 to $5.16, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":73152,"source":{"system":"sec-edgar","filing":"0001734424-26-000001","document":"form4-02202026_040203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528115/000173442426000001/form4-02202026_040203.xml","form_type":"4"}},{"id":1235289,"issuer":{"id":5011,"kind":"organization","name":"Annexon, Inc.","symbol":"ANNX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-03T21:55:35.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":228225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from February 27, 2025 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":228225,"derivative":{"exercise_price":2.5,"expiration_date":"2034-02-27","underlying":"Common Stock","underlying_shares":228225},"source":{"system":"sec-edgar","filing":"0001415889-25-006195","document":"form4-03032025_090331.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1528115/000141588925006195/form4-03032025_090331.xml","form_type":"4"}},{"id":1235288,"issuer":{"id":5011,"kind":"organization","name":"Annexon, Inc.","symbol":"ANNX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-03-03T21:55:35.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":44963,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on February 27 of each year, with the first 1/3rd vesting on February 27, 2026."}],"balance_after":78442,"source":{"system":"sec-edgar","filing":"0001415889-25-006195","document":"form4-03032025_090331.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528115/000141588925006195/form4-03032025_090331.xml","form_type":"4"}},{"id":1255188,"issuer":{"id":5011,"kind":"organization","name":"Annexon, Inc.","symbol":"ANNX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-20T21:54:09.000Z","date":"2025-02-18","kind":"sale","planned":false,"acquired":false,"shares":5521,"price":2.96,"value":16342.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $2.855 to $3.12, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":33479,"source":{"system":"sec-edgar","filing":"0001415889-25-004891","document":"form4-02202025_090205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528115/000141588925004891/form4-02202025_090205.xml","form_type":"4"}},{"id":1628190,"issuer":{"id":5011,"kind":"organization","name":"Annexon, Inc.","symbol":"ANNX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-21T21:32:05.000Z","date":"2024-02-16","kind":"grant","planned":false,"acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from February 16, 2024 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":160000,"derivative":{"exercise_price":5.13,"expiration_date":"2034-02-16","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001415889-24-004627","document":"form4-02212024_040231.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1528115/000141588924004627/form4-02212024_040231.xml","form_type":"4"}},{"id":1628189,"issuer":{"id":5011,"kind":"organization","name":"Annexon, Inc.","symbol":"ANNX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-02-21T21:32:05.000Z","date":"2024-02-16","kind":"grant","planned":false,"acquired":true,"shares":39000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on February 16 of each year, with the first 1/3rd vesting on February 16, 2025."}],"balance_after":39000,"source":{"system":"sec-edgar","filing":"0001415889-24-004627","document":"form4-02212024_040231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528115/000141588924004627/form4-02212024_040231.xml","form_type":"4"}},{"id":1817602,"issuer":{"id":5011,"kind":"organization","name":"Annexon, Inc.","symbol":"ANNX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-02T21:07:38.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on the first anniversary measured from July 27, 2023 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":275000,"derivative":{"exercise_price":3.54,"expiration_date":"2033-08-01","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001610717-23-000220","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528115/000161071723000220/form4.xml","form_type":"4"}},{"id":1932267,"issuer":{"id":77428,"kind":"organization","name":"Unity Biotechnology, Inc.","symbol":"UBX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2023-04-03T16:51:04.000Z","date":"2023-03-31","kind":"sale","planned":false,"acquired":false,"shares":420,"price":1.7,"value":714.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading instruction to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes Restricted Stock Units which vest over time measured from the grant date."}],"balance_after":62817,"source":{"system":"sec-edgar","filing":"0000899243-23-010235","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463361/000089924323010235/doc4.xml","form_type":"4"}},{"id":1952108,"issuer":{"id":77428,"kind":"organization","name":"Unity Biotechnology, Inc.","symbol":"UBX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2023-03-15T17:02:06.000Z","date":"2023-03-14","kind":"sale","acquired":false,"shares":1005,"price":4,"value":4020.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading instruction to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes Restricted Stock Units which vest over time measured from the grant date."}],"balance_after":63237,"source":{"system":"sec-edgar","filing":"0000899243-23-008588","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463361/000089924323008588/doc4.xml","form_type":"4"}},{"id":2032816,"issuer":{"id":77428,"kind":"organization","name":"Unity Biotechnology, Inc.","symbol":"UBX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2023-02-03T16:33:29.000Z","date":"2023-02-02","kind":"sale","acquired":false,"shares":863,"price":4.84,"value":4176.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading instruction to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes Restricted Stock Units which vest over time measured from the grant date."}],"balance_after":64242,"source":{"system":"sec-edgar","filing":"0000899243-23-003870","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463361/000089924323003870/doc4.xml","form_type":"4"}},{"id":2085038,"issuer":{"id":77428,"kind":"organization","name":"Unity Biotechnology, Inc.","symbol":"UBX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2022-12-15T16:44:40.000Z","date":"2022-12-14","kind":"sale","acquired":false,"shares":1016,"price":2.85,"value":2895.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading instruction to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes Restricted Stock Units which vest over time measured from the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects a 1-for-10 reverse stock split of the Issuer's common stock, effected by the Issuer on October 19, 2022, which was exempt from reporting pursuant to Rule 16a-9."}],"balance_after":65105,"source":{"system":"sec-edgar","filing":"0000899243-22-038614","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463361/000089924322038614/doc4.xml","form_type":"4"}},{"id":2108513,"issuer":{"id":77428,"kind":"organization","name":"Unity Biotechnology, Inc.","symbol":"UBX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-21T17:35:08.000Z","date":"2022-11-18","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares vest and become exercisable pursuant to the following schedule: One-eighth of the shares subject to the option vest in successive, equal quarterly installments starting on February 18, 2023, subject to the Reporting Person's continued service to Issuer through the applicable vesting date."}],"balance_after":65000,"derivative":{"exercise_price":2.38,"expiration_date":"2032-11-18","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0000899243-22-036543","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463361/000089924322036543/doc4.xml","form_type":"4"}},{"id":2158387,"issuer":{"id":77428,"kind":"organization","name":"Unity Biotechnology, Inc.","symbol":"UBX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2022-09-15T16:10:36.000Z","date":"2022-09-14","kind":"sale","acquired":false,"shares":10923,"price":0.48,"value":5243.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading instruction to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes Restricted Stock Units which vest over time measured from the grant date."}],"balance_after":661213,"source":{"system":"sec-edgar","filing":"0000899243-22-031139","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463361/000089924322031139/doc4.xml","form_type":"4"}},{"id":2220103,"issuer":{"id":77428,"kind":"organization","name":"Unity Biotechnology, Inc.","symbol":"UBX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2022-06-28T18:11:25.000Z","date":"2022-06-27","kind":"sale","acquired":false,"shares":4398,"price":0.59,"value":2594.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading plan to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes Restricted Stock Units which vest over time measured from the grant date."}],"balance_after":672136,"source":{"system":"sec-edgar","filing":"0000899243-22-024439","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463361/000089924322024439/doc4.xml","form_type":"4"}},{"id":2224059,"issuer":{"id":77428,"kind":"organization","name":"Unity Biotechnology, Inc.","symbol":"UBX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2022-06-22T16:49:54.000Z","date":"2022-06-21","kind":"sale","acquired":false,"shares":3697,"price":0.62,"value":2292.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading plan to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes Restricted Stock Units which vest over time measured from the grant date."}],"balance_after":676534,"source":{"system":"sec-edgar","filing":"0000899243-22-023584","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463361/000089924322023584/doc4.xml","form_type":"4"}},{"id":2231421,"issuer":{"id":77428,"kind":"organization","name":"Unity Biotechnology, Inc.","symbol":"UBX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2022-06-15T16:34:21.000Z","date":"2022-06-14","kind":"tax_withholding","acquired":false,"shares":10530,"price":0.63,"value":6633.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading plan to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes Restricted Stock Units which vest over time measured from the grant date."}],"balance_after":680231,"source":{"system":"sec-edgar","filing":"0000899243-22-022587","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463361/000089924322022587/doc4.xml","form_type":"4"}},{"id":2311137,"issuer":{"id":77428,"kind":"organization","name":"Unity Biotechnology, Inc.","symbol":"UBX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2022-04-01T16:24:28.000Z","date":"2022-03-31","kind":"tax_withholding","acquired":false,"shares":4188,"price":1.14,"value":4774.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading plan to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes Restricted Stock Units which vest over time measured from the grant dat"}],"balance_after":690761,"source":{"system":"sec-edgar","filing":"0000899243-22-013110","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463361/000089924322013110/doc4.xml","form_type":"4"}},{"id":2333165,"issuer":{"id":77428,"kind":"organization","name":"Unity Biotechnology, Inc.","symbol":"UBX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2022-03-15T16:53:05.000Z","date":"2022-03-14","kind":"tax_withholding","acquired":false,"shares":10581,"price":0.88,"value":9311.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading plan to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes Restricted Stock Units which vest over time measured from the grant date."}],"balance_after":694949,"source":{"system":"sec-edgar","filing":"0000899243-22-011062","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463361/000089924322011062/doc4.xml","form_type":"4"}},{"id":2394373,"issuer":{"id":77428,"kind":"organization","name":"Unity Biotechnology, Inc.","symbol":"UBX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-15T17:23:18.000Z","date":"2022-02-09","kind":"grant","acquired":true,"shares":183333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares vest and become exercisable pursuant to the following schedule: One Third of the shares subject to the option vest on February 9, 2023 (the \"Vesting Commencement Date\"), and the remaining shares subject to the option vest in 24 successive, equal monthly installments thereafter on each monthly anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."}],"balance_after":183333,"derivative":{"exercise_price":1.06,"expiration_date":"2032-02-09","underlying":"Common Stock","underlying_shares":183333},"source":{"system":"sec-edgar","filing":"0000899243-22-006454","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1463361/000089924322006454/doc4.xml","form_type":"4"}},{"id":2394372,"issuer":{"id":77428,"kind":"organization","name":"Unity Biotechnology, Inc.","symbol":"UBX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2022-02-15T17:23:18.000Z","date":"2022-02-09","kind":"grant","acquired":true,"shares":45833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") one third of which vests on February 9, 2023 with the remaining RSUs vesting in equal quarterly installments over a two year period thereafter. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes RSUs which vest over time measured from the grant date."}],"balance_after":705530,"source":{"system":"sec-edgar","filing":"0000899243-22-006454","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463361/000089924322006454/doc4.xml","form_type":"4"}},{"id":2471514,"issuer":{"id":77428,"kind":"organization","name":"Unity Biotechnology, Inc.","symbol":"UBX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2021-12-15T16:26:55.000Z","date":"2021-12-14","kind":"tax_withholding","acquired":false,"shares":10614,"price":1.63,"value":17300.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading plan to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes Restricted Stock Units which vest over time measured from the grant date."}],"balance_after":659697,"source":{"system":"sec-edgar","filing":"0000899243-21-048359","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463361/000089924321048359/doc4.xml","form_type":"4"}},{"id":2554296,"issuer":{"id":77428,"kind":"organization","name":"Unity Biotechnology, Inc.","symbol":"UBX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2021-10-01T21:57:34.000Z","date":"2021-03-30","kind":"tax_withholding","acquired":false,"shares":40564,"price":2.95,"value":119663.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading plan to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes Restricted Stock Units which vest over time measured from the grant date."}],"balance_after":670311,"source":{"system":"sec-edgar","filing":"0000899243-21-038737","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463361/000089924321038737/doc4.xml","form_type":"4"}},{"id":2653388,"issuer":{"id":77428,"kind":"organization","name":"Unity Biotechnology, Inc.","symbol":"UBX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-28T17:16:40.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the stock option vest and become exercisable in successive, equal monthly installments over a 48-month period commencing on June 24, 2021 (the \"Vesting Commencement Date\"), so that 100% of the shares become fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":100000,"derivative":{"exercise_price":4.18,"expiration_date":"2031-06-23","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-21-026228","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1463361/000089924321026228/doc4.xml","form_type":"4"}},{"id":2653387,"issuer":{"id":77428,"kind":"organization","name":"Unity Biotechnology, Inc.","symbol":"UBX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2021-06-28T17:16:40.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") which vest in equal annual installments over a three year period measured from June 24, 2021.  Each RSU represents a contingent right to receive one share of Common Stock of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes RSUs which vest over time measured from the grant date."}],"balance_after":710875,"source":{"system":"sec-edgar","filing":"0000899243-21-026228","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463361/000089924321026228/doc4.xml","form_type":"4"}},{"id":2657050,"issuer":{"id":77428,"kind":"organization","name":"Unity Biotechnology, Inc.","symbol":"UBX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2021-06-23T17:03:15.000Z","date":"2021-06-21","kind":"tax_withholding","acquired":false,"shares":3515,"price":4.18,"value":14692.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the release of shares subject to vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes Restricted Stock Units which vest over time measured from the grant date."}],"balance_after":685875,"source":{"system":"sec-edgar","filing":"0000899243-21-025521","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463361/000089924321025521/doc4.xml","form_type":"4"}},{"id":2763860,"issuer":{"id":77428,"kind":"organization","name":"Unity Biotechnology, Inc.","symbol":"UBX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2021-04-01T17:13:19.000Z","date":"2021-03-30","kind":"tax_withholding","acquired":false,"shares":2829,"price":5.73,"value":16210.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the release of shares subject to vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes Restricted Stock Units which vest over time measured from the grant date."}],"balance_after":689390,"source":{"system":"sec-edgar","filing":"0000899243-21-014349","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463361/000089924321014349/doc4.xml","form_type":"4"}},{"id":3031277,"issuer":{"id":77428,"kind":"organization","name":"Unity Biotechnology, Inc.","symbol":"UBX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-09-15T21:01:51.000Z","date":"2020-09-13","kind":"grant","acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") one-third of which vests on September 13, 2021 with the remaining RSUs vesting in equal quarterly installments over a two year period thereafter.   Each RSU represents a contingent right to receive one share of Common Stock of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") one-third of which vests on September 13, 2021 with the remaining RSUs vesting in equal quarterly installments over a two year period thereafter.   Each RSU represents a contingent right to receive one share of Common Stock of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes RSUs which vest over time measured from the grant date."}],"balance_after":692219,"source":{"system":"sec-edgar","filing":"0000899243-20-025182","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463361/000089924320025182/doc4.xml","form_type":"4"}},{"id":3100807,"issuer":{"id":77428,"kind":"organization","name":"Unity Biotechnology, Inc.","symbol":"UBX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-06-24T16:59:14.000Z","date":"2020-06-22","kind":"tax_withholding","acquired":false,"shares":2483,"price":9.67,"value":24010.61,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the release of shares subject to vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes Restricted Stock Units which vest over time measured from the grant date."}],"balance_after":452219,"source":{"system":"sec-edgar","filing":"0000899243-20-017554","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463361/000089924320017554/doc4.xml","form_type":"4"}},{"id":3189096,"issuer":{"id":77428,"kind":"organization","name":"Unity Biotechnology, Inc.","symbol":"UBX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-01T17:08:02.000Z","date":"2020-03-30","kind":"grant","acquired":true,"shares":98490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the stock option vest and become exercisable in successive, equal monthly installments over a 48-month period commencing on March 30, 2020 (the \"Vesting Commencement Date\"), so that 100% of the shares become fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":98490,"derivative":{"exercise_price":5.95,"expiration_date":"2030-03-29","underlying":"Common Stock","underlying_shares":98490},"source":{"system":"sec-edgar","filing":"0000899243-20-009846","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1463361/000089924320009846/doc4.xml","form_type":"4"}},{"id":3189095,"issuer":{"id":77428,"kind":"organization","name":"Unity Biotechnology, Inc.","symbol":"UBX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-04-01T17:08:02.000Z","date":"2020-03-30","kind":"grant","acquired":true,"shares":24255,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") which vest in equal annual installments over a three year period measured from March 30, 2020.   Each RSU represents a contingent right to receive one share of Common Stock of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes RSUs which vest over time measured from the grant date."}],"balance_after":454702,"source":{"system":"sec-edgar","filing":"0000899243-20-009846","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463361/000089924320009846/doc4.xml","form_type":"4"}},{"id":3480056,"issuer":{"id":77428,"kind":"organization","name":"Unity Biotechnology, Inc.","symbol":"UBX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-24T16:17:47.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":106800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest and become exercisable in 48 successive, equal monthly installments measured from June 20, 2019, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":106800,"derivative":{"exercise_price":9,"expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":106800},"source":{"system":"sec-edgar","filing":"0001567619-19-013882","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1463361/000156761919013882/doc1.xml","form_type":"4"}},{"id":3480055,"issuer":{"id":77428,"kind":"organization","name":"Unity Biotechnology, Inc.","symbol":"UBX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-06-24T16:17:47.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":21075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"RSUs which vest 1/3 annually over 3 years measured from June 20, 2019."}],"balance_after":430447,"source":{"system":"sec-edgar","filing":"0001567619-19-013882","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463361/000156761919013882/doc1.xml","form_type":"4"}},{"id":3944236,"issuer":{"id":77428,"kind":"organization","name":"Unity Biotechnology, Inc.","symbol":"UBX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Series C Preferred Stock","published_at":"2018-05-07T18:20:00.000Z","date":"2018-05-07","kind":"exercise","acquired":false,"shares":1630,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The expiration date is not relevant to the conversion of these securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1630},"source":{"system":"sec-edgar","filing":"0001140361-18-022044","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1463361/000114036118022044/doc1.xml","form_type":"4"}},{"id":3944235,"issuer":{"id":77428,"kind":"organization","name":"Unity Biotechnology, Inc.","symbol":"UBX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Series B Preferred Stock","published_at":"2018-05-07T18:20:00.000Z","date":"2018-05-07","kind":"exercise","acquired":false,"shares":74048,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The expiration date is not relevant to the conversion of these securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":74048},"source":{"system":"sec-edgar","filing":"0001140361-18-022044","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1463361/000114036118022044/doc1.xml","form_type":"4"}},{"id":3944234,"issuer":{"id":77428,"kind":"organization","name":"Unity Biotechnology, Inc.","symbol":"UBX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-05-07T18:20:00.000Z","date":"2018-05-07","kind":"exercise","acquired":true,"shares":1630,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering."}],"balance_after":409372,"source":{"system":"sec-edgar","filing":"0001140361-18-022044","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1463361/000114036118022044/doc1.xml","form_type":"4"}},{"id":3944233,"issuer":{"id":77428,"kind":"organization","name":"Unity Biotechnology, Inc.","symbol":"UBX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-05-07T18:20:00.000Z","date":"2018-05-07","kind":"exercise","acquired":true,"shares":74048,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering."}],"balance_after":407742,"source":{"system":"sec-edgar","filing":"0001140361-18-022044","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463361/000114036118022044/doc1.xml","form_type":"4"}},{"id":3945565,"issuer":{"id":77428,"kind":"organization","name":"Unity Biotechnology, Inc.","symbol":"UBX"},"owners":[{"id":62769,"kind":"person","name":"Dananberg Jamie","position":1,"cik":"0001734424","reported_name":"Dananberg Jamie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-04T18:20:24.000Z","date":"2018-05-02","kind":"grant","acquired":true,"shares":30508,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest as to 25% of the shares on the one-year anniversary of May 2, 2018, and 1/48th of the shares shall vest on each monthly anniversary thereafter, subject to the optionee remainining a service provider to the Issuer on each such vesting date."}],"balance_after":30508,"derivative":{"exercise_price":17,"expiration_date":"2028-05-01","underlying":"Common Stock","underlying_shares":30508},"source":{"system":"sec-edgar","filing":"0001140361-18-021811","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463361/000114036118021811/doc1.xml","form_type":"4"}}]}